Speaker: 

Mark Olaf, DO, Staff Member, Geisinger - has nothing to disclose.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Describe the risks and benefits of solicited use in critically ill patients requiring intubation 
• Describe risks of post intubation hypotension with agents used in RSI
• Describe common errors in endotracheal intubation

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Mark F Olaf, DO has no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant.